AtaGenix is a leading contract research organization (CRO) founded in 2011, specializing in antibody and protein development services for research, diagnostics, and therapeutic R&D. Our expertise spans Single B cell, phage display, nanobody discovery, and stable cell line generation. In 2023, we launched our catalog brand, abinScience, to provide premium life science reagents that accelerate discovery. With over 14 years of proven experience and innovative solutions, AtaGenix delivers high-quality, reliable products and services to researchers worldwide.
ARTIDIS
Artidis® AG is a pioneering clinical stage health technology company that aims to set the gold standard in tissue analysis and therapy optimization. By combining its nanotechnology platform for rapid tissue analysis with a holistic data solution, Artidis® accelerates drug discovery, tissue engineering, and personalized treatment. Artidis® focuses its research and development efforts on solid tumors to enhance responses to chemo, immunotherapy, and cell therapies, driving precision in cancer care.
Arochi & Lindner
Arochi & Lindner: Premier Legal Solutions for the Life Sciences and Pharmaceutical Industries With more than 30 years of experience, Arochi & Lindner is a leading law firm in Mexico and Spain, known for its excellence in Intellectual Property, Litigation, and Regulatory Advisory. Our Life Sciences practice stands out as one of the most robust in the market, providing strategic legal solutions for companies in the pharmaceutical, biotechnology, medical device, food, cosmetics, and agricultural sectors. We recognize that the Life Sciences sector is constantly evolving and encounters complex regulatory challenges. That’s why we offer thorough legal counsel that covers a wide range of services, including trademark and patent registration, obtaining sanitary authorizations from COFEPRIS, drafting licensing agreements, ensuring regulatory compliance, handling patent litigation, and navigating public procurement processes. Our multidisciplinary team — which includes attorneys, chemists, engineers, and biotechnologists — combines technical and legal expertise to provide practical and efficient solutions aligned with our clients’ business goals. We have successfully represented drug companies in high-profile patent disputes and have managed groundbreaking innovations, such as the first microorganism deposit at Mexico’s National Center for Genetic Resources (CNRG). At Arochi & Lindner, we don’t just protect innovation — we empower it. Our mission is to act as a strategic partner for companies transforming health, technology, and quality of life through science.
Arima Genomics
Arima Genomics, Inc. is advancing human health and the life sciences by revealing actionable genomic insights. Researchers and clinicians use Arima Genomics’ innovative products and services to gain unparalleled access to the three-dimensional (3D) organization of the genome. This advanced technology enables exploration of disease mechanisms, the discovery of novel biomarkers and therapeutic targets, and identification of gene fusions to aid in patient management. To learn more, visit www.arimagenomics.com. | Arima Genomics, Inc. is advancing human genetics research by providing unparalleled insights into the three-dimensional (3D) organization of the genome. Researchers and clinicians use Arima Genomics’ innovative technologies to explore the structural and regulatory landscape of DNA, uncovering genetic mechanisms that drive health and disease. This advanced technology enables the discovery of novel biomarkers, therapeutic targets, and gene regulatory interactions, empowering breakthroughs in personalized medicine and genomic research.
Argentina Pavilion
Argentina export promotion agency | . | Agencia Argentina de Inversiones y Comercio Exterior
Argonaut Manufacturing Services
Argonaut Manufacturing Services Inc. is a contract manufacturing organization (CMO) headquartered in Carlsbad, CA. The company is dedicated to supporting life science, diagnostic, and biopharmaceutical innovators with high quality GMP manufacturing services in the areas of formulation, aseptic fill/finish, kitting, and distribution. Argonaut’s Aseptic Drug Product Fill/Finish facility is designed for biopharmaceutical product teams in pre-clinical through commercial phase who need to maximize product yield and reduce risk without compromising product quality and safety. Argonaut has experience manufacturing biologics, oligos, peptides, small molecules, and vaccines and can provide aseptic formulation of high-viscosity and adjuvanted molecules. The fully automated filling line features SKAN isolators, single-use RTU consumables, and 100% in-line non-destructive weight checks. Earlier this year, Argonaut announced a significant capital investment to expand the company’s fill/finish offering with an additional isolator-based filling line that will support clinical and commercial production of vials, cartridges, and syringes. To support Diagnostic and Life Science organizations, Argonaut provides partners with scalable and flexible manufacturing options, from product configuration to shipping and storage, to complete supply chain management. Argonaut has proprietary lyophilization technologies for diagnostic solutions which greatly simplify POCT devices, extend shelf-life, and allow storage and shipping at ambient temperatures. Argonaut recently launched LyoDots™, the world’s smallest lyophilized spheres to work in miniaturized diagnostic, POCT devices, and microfluidic applications. Find out more about how Argonaut can assist with your manufacturing needs by visiting https://www.argonautms.com or calling +1 888-834-8892. | Argonaut Manufacturing Services Inc. is a contract manufacturing organization (CMO) headquartered in Carlsbad, CA. The company is dedicated to supporting life science, diagnostic, and biopharmaceutical innovators with high quality GMP manufacturing services in the areas of formulation, aseptic fill/finish, kitting, and distribution. Argonaut’s Aseptic Drug Product Fill/Finish facility is designed for biopharmaceutical product teams in pre-clinical through commercial phase who need to maximize product yield and reduce risk without compromising product quality and safety. Argonaut has experience manufacturing biologics, oligos, peptides, small molecules, and vaccines and can provide aseptic formulation of high-viscosity and adjuvanted molecules. The fully automated Bausch+Ströbel filling line features SKAN isolators, single-use RTU consumables, and 100% in-line non-destructive weight checks. In March of 2024, Argonaut announced the completion of a $45 million financing round to support its new drug product fill/finish expansion. This expansion will quadruple Argonaut’s existing drug product fill/finish capacity and will augment existing vial filling capabilities with the ability to fill syringes and cartridges for clinical and commercial supply. To support Diagnostic and Life Science organizations, Argonaut provides partners with scalable and flexible manufacturing options, from product configuration to shipping and storage, to complete supply chain management. Argonaut has proprietary lyophilization technologies for IVD solutions which greatly simplify POCT devices, extend shelf-life, and allow storage and shipping at ambient temperatures. Argonaut’s proprietary lyophilization technology includes LyoDots™, the world’s smallest lyophilized spheres designed to work in miniaturized diagnostic, POCT devices, and microfluidic applications. For Combination Products, Argonaut provides custom manufacturing expertise for devices including microelectronics, injectors, oral delivery, and topical systems. We support both single-entity products and co-packaged products with assembly and packaging in ISO 8 cleanrooms. Extended services include CCIT, chemical compatibility testing, process validation, stability studies, and regulatory support. Argonaut is FDA registered and CA FDB-audited, and is compliant with ISO 13485:2016, cGMP, and quality system regulations 21 CFR 820 including Part 4 update, 21 CFR 210, 21 CFR 211. Find out more about how Argonaut can assist with your manufacturing needs by visiting https://www.argonautms.com or calling +1 888-834-8892. | Argonaut Manufacturing Services is your CMO for aseptic fill finish, IVD & life science kitting, and drug device combination product manufacturing. Our experienced team provides your organization with flexible and responsive manufacturing options. Based in Carlsbad CA, we provide US based manufacturing services in our FDA inspected facilities, saving your team both time and infrastructure capital costs. Argonaut’s aseptic drug product fill finish facility supports clients at pre-clinical through commercial phase who need to maximize product yield and reduce risk for high value biopharmaceutical products. We specialize in the formulation and aseptic filling of biologics, oligopeptides, peptides, and vaccines. Argonaut’s equipment and process are optimized to provide “near zero” line losses and as such, we have extensive experience filling low volume high value rare disease products. Our fill finish services include expert formulation (including complicated formulations), EU Annex 1 compliant aseptic filling, visual inspection, bulk packaging, storage, logistics and distribution support. Starting in Q4 2025, Argonaut will be offering aseptic filling of prefilled syringes and cartridges in addition to vials on our new filling line designed for mid to large scale batches. For Drug Device Combination Products, Argonaut delivers custom manufacturing expertise including microelectronics, injectors, oral delivery, and topical systems. We support both single-entity products and co-packaged products with assembly and packaging in ISO 8 cleanrooms. DDCP extended services include CCIT, chemical compatibility testing, process validation, stability studies, and regulatory support. Argonaut’s IVD and Life Science kitting services provides full-service contract manufacturing for POCT, IVD and RUO products. From formulation through kitting, sterilization, and warehousing, our experienced team has manufactured +4.2M kits. We feature the world’s smallest lyophilized format- LyoDots®- that are specifically designed for cartridges and POCT. Using Argonaut, you get the flexibility and scale that allows your team to rapidly adjust to market conditions. Argonaut is FDA registered and CA FDB-audited, and is compliant with ISO 13485:2016, cGMP, and quality system regulations 21 CFR 820 including Part 4 update, 21 CFR 210, 21 CFR 211. Our fill finish services are EU Annex 1 Compliant. Find out more about how Argonaut Manufacturing Services can assist with your manufacturing needs by visiting https://www.argonautms.com or calling +1 888-834-8892.
Ardigen
Ardigen is your end-to-end trusted partner in the data-to-insights enablement journey that powers modern, AI-data-driven drug discovery. We help life science organizations transform fragmented, multimodal biomedical data into AI-ready foundations, actionable insights, and scalable discovery workflows. Our approach bridges the gap between data potential and discovery impact, grounded in a science-first model that starts with the biological question and aligns every step to measurable, real-world scientific outcomes. | Ardigen, a world-leading AI CRO, stands at the forefront of enabling AI transformation for the biotech and pharmaceutical sectors. Our objective is to increase the probability of success in the drug development process. We utilize our advanced platforms and deep expertise to turn vast amounts of data into pivotal, ready-to-use scientific insights. Leveraging our expertise, we also enhance the infrastructure that allows our clients to integrate and utilize these capabilities seamlessly within their organizations. | Ardigen is a leading AI Contract Research Organisation (CRO) dedicated to increasing the success rate of drug discovery. Recognized among the top 5% of AI in drug discovery companies worldwide, Ardigen integrates expertise in biology, bioinformatics, machine learning, and software engineering to deliver advanced computational solutions exclusively tailored for the biotechnology and pharmaceutical sectors. Over the past 10 years, we have earned the trust of over 120 clients, including 15 major pharmaceutical companies, by providing exceptional in silico research and data engineering services.
Arbele
Arbele is a clinical stage biopharmaceutical company developing targeted immunotherapy to treat gastrointestinal cancers including colorectal, gastric, pancreatic, hepatic and esophageal cancers. Cabotamig (ARB202), a CDH17/CD3 bispecific BiTE molecule has shown good safety profiles and demonstrated target engagement with antitumor activities. Subsequent lines of therapeutics are ARB203 BiTE, ARB102 ADC, and ARB011 CAR expect to enter IND and clinical stages in 2024/25. To detect and intercept cancer development and progressions, our diagnostic affiliate has developed companion tissue diagnostics for anti-CDH17 therapies as well as proprietary liquid biopsy immunoassays. The company welcomes strategic licensing partnership to accelerate multicenter clinical studies and business expansion globally. | Arbele is a CDH17-pioneer biotech company spearheading potential first-in-class/best-in-class immunotherapies (TCE and ADC) to treat pancreatic and advanced colorectal cancers (2L+). To accelerate the clinical development regulatory pathway, TibTech (an associated Medtech company) has established companion diagnostic platforms to test CA17 expression levels for both tissues and blood samples. Strategic partnerships with BioAI Healthcare and IVD companies position us at a leading competitor over other players.